PDCD1 and neoplasm: Depletion of Tregs was equally as effective as CD4+ T cell depletion at enhancing the anti-tumor immunity induced by combination therapy with IL PV-10 and anti-PD-1 antibodies (p<0.05 compared to all other treatment groups).